Skip to content
DataLookout
Menu

NCT06629636

Investigate the Efficacy of Using NMN to Improve Embryo Development Capacity.

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 18 words Show 5 more changesShow less
    • Trial completed
    • Primary completion date changed from estimate of Sep 30, 2025 to Dec 30, 2025
    • Study completion date changed from estimate of Dec 31, 2026 to Dec 31, 2025
    • Site details revised
    • Publications: details revised at 7 of 7 entries
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Embryo development rate
Timeframe: Up to 8 weeks post-intervention
Changes in metabolic status
Timeframe: Up to 8 weeks post-intervention
Clinical pregnancy rate
Timeframe: Up to 12months post-intervention

Secondary (7)

Live Birth rates
Endocrine hormones including AMH
Average egg retrieval capacity per person
Additional in vitro fertilization - outcome indicators
Chemical pregnancy rate
Show 2 moreShow less
Pregnancy complication
Abortion rate

Arms and interventions

NMN interventionActive comparator

NMN capsules (total of 900mg/day) for 8 weeks

Placebo interventionPlacebo comparator

NMN-free placebo capsules for 8 weeks

Dietary supplements: NMN capsule

Other: Placebo

Sites

1 site in 1 country

  • IVF Namba Clinic, Sankaky Medical CorporationOsaka, Osaka, Japan